Latest Market Outlook News

Clover Corporation delivered a robust FY25 with strong second-half sales and operational milestones, positioning itself for continued growth in FY26 amid ongoing innovation and market expansion.

QuickFee Limited reports a pivotal FY25 with strong revenue growth and positive underlying profitability, alongside a strategic sale of its US Pay Now business and a proposed capital return to shareholders.

Metallium Ltd has secured exclusive rights to apply its breakthrough Flash Joule Heating technology to the heavy rare earth-rich Harts Range Project, achieving an unprecedented 20-fold upgrade in rare earth concentration. This deal positions Metallium as a key player in Western critical minerals supply amid global geopolitical tensions.

ALS Limited reported a robust half-year performance with underlying revenue up 13.3% and net profit after tax rising 17.2%, driven by strong growth in both Commodities and Life Sciences divisions. The company also declared a higher interim dividend and advanced its global expansion strategy.

Sunrise Energy Metals has raised A$46 million through a strategic placement to advance pre-construction at its flagship Syerston Scandium Project, positioning itself as a key player in the scandium market amid supply uncertainties.

Nexion Group has finalized the sale of its Nexion Networks and Blue Sky Telecom subsidiaries, pivoting its focus towards AI-driven business intelligence through Fuse Forward.

Metals X Limited has updated its Renison Tin Operations Ore Reserve, reporting a 7.5 million tonne reserve with 102,720 tonnes of contained tin, reflecting an 8.5% decline from last year but affirming a near-decade mine life.

Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.

Comms Group Limited reports a strong start to FY26 with a 41.6% revenue increase and successful integration of TasmaNet, positioning the company for ambitious annual targets.

The ACCC has decided not to oppose Southern Cross Media’s proposed acquisition of Seven West Media, finding limited competition concerns amid evolving digital media landscapes.

Sagalio Energy Limited’s shares have been suspended from ASX trading due to compliance concerns, leaving investors in the dark about the company’s next steps.

Actinogen Medical’s XanaMIA Phase 2b/3 trial for Alzheimer’s disease has received a positive safety recommendation from its independent Data Monitoring Committee, allowing the study to proceed unchanged. Investors now await the critical efficacy analysis scheduled for January 2026.